Australia  

FDA Approves Remdesivir to Treat COVID-19

Video Credit: Cover Video STUDIO - Duration: 01:20s - Published
FDA Approves Remdesivir to Treat COVID-19

FDA Approves Remdesivir to Treat COVID-19

US regulators have approved the use of remdesivir, an antiviral medicine, for COVID-19 treatment.


You Might Like


πŸ’‘ One News Page Knowledge: Other News Mentions

Remdesivir Remdesivir Antiviral drug

The WHO No Longer Recommends Remdesivir For COVID-19 Patients [Video]

The WHO No Longer Recommends Remdesivir For COVID-19 Patients

The FDA approved remdesivir as a treatment for severe COVID-19 cases last month. This is after granting emergency authorization in May, reports Business Insider. But on Thursday, the WHO announced it will not recommend the drug's use for COVID-19 patients. "There is currently no evidence that it improves survival or the need for ventilation," the organization said. Remdesivir was the first coronavirus treatment to receive emergency authorization from the FDA.

Credit: Wochit News    Duration: 00:39Published
Remdesivir has little effect on COVID deaths: WHO [Video]

Remdesivir has little effect on COVID deaths: WHO

Anti-viral medication remdesivir was found to have little or no effect on COVID-19 patients' length of hospital stay or chances of survival, according to a clinical trial by the World Health Organization. Adam Reed has more.

Credit: Reuters Studio    Duration: 01:36Published
COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated [Video]

COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated

A prayer vigil was held on Sunday evening for President Trump and First Lady Melania Trump by the Indian American community to wish them a speedy recovery. His supporters not only gathered outside the hospital but also showed support virtually from cities across the United States. The community members chanted mantras and echoed the sound of the conch shell or Shankha for the speedy recovery of President Trump and the First Lady. Sentinels of Dharma, a Hindu American organization hosted the event. During the prayer meeting, Indian Americans also endorsed President Trump in his re-election bid and reached out to other community members all over the country to campaign in his favour. President Trump could be released from the Walter Reed National Military Medical Center as soon as Monday, his medical team said in an update on Sunday to members of the White House press pool, as the president continues his treatment on dexamethasone and Remdesivir to fight coronavirus. President Trump was admitted to Walter Reed on Friday after he announced that he and the First Lady had tested positive for the coronavirus.

Credit: ANI    Duration: 02:59Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Moderna's COVID-19 Vaccine Designed Designed In 2 Days [Video]

Moderna's COVID-19 Vaccine Designed Designed In 2 Days

Moderna's coronavirus vaccine candidate is 94.5% effective at protecting people against COVID-19. The candidate took under a year to develop and test, which is years faster than previous vaccines. The company designed its vaccine candidate in just two days, says Business Insider. In contrast, traditional vaccines can take years to design. Vaccines will hopefully be rolled out by Spring of 2021.

Credit: Wochit News    Duration: 00:33Published
Questions over AstraZeneca's COVID-19 vaccine data [Video]

Questions over AstraZeneca's COVID-19 vaccine data

British drugmaker AstraZeneca is working with regulators to investigate a lower dosage of its vaccine that performed better than a full dosage, a spokesman for the company said on Thursday, after its chief executive was quoted as saying an additional global trial was likely. This report produced by Jillian Kitchener.

Credit: Reuters - Politics    Duration: 01:29Published
Dosing Mix-up Raises Questions About New COVID Vaccine [Video]

Dosing Mix-up Raises Questions About New COVID Vaccine

A manufacturing error is raising concerns about a promising COVID-19 vaccine being developed. The vaccine was developed by pharmaceutical company AstraZeneca and the University of Oxford. Less than a week after we learned about it, the developers have admitted to a manufacturing error. The error resulted from two different doses during the recently concluded phase III trial. AstraZeneca and the University of Oxford described the vaccine as being 70% effective.

Credit: Wochit News    Duration: 00:39Published
Elephant safari resumes in Jaipur's Amer Fort [Video]

Elephant safari resumes in Jaipur's Amer Fort

Elephant rides at Jaipur's Amer Fort resumed after months-long closure. The rides were prohibited due to COVID pandemic. Mahouts breathed a sigh of relief after state govt granted permission. Elephant safari is one of the key attractions at famous Amer Fort.

Credit: ANI    Duration: 02:02Published

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

COVID-19 Vaccine May Cause Flu-Like Symptoms [Video]

COVID-19 Vaccine May Cause Flu-Like Symptoms

Americans need to be prepared for the possibility that they may feel a little unwell. After you get a coronavirus vaccine, if one is authorized, you may experience some negative side effects. The CDC met to discuss whether to recommend the use of any Covid-19 vaccines. The US Food and Drug Administration or FDA is the agency that might authorize one. Volunteers in vaccine trials have reported they frequently feel flu-like effects after getting vaccinated.

Credit: Wochit News    Duration: 00:39Published
Dow Jumps 210 Points On Vaccine News From AstraZeneca [Video]

Dow Jumps 210 Points On Vaccine News From AstraZeneca

On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%

Credit: Wochit News    Duration: 00:37Published
Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine [Video]

Pfizer submits Emergency Use Authorization request to FDA for its COVID-19 vaccine

Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.

Credit: ABC Action News    Duration: 01:51Published
How Long Will It Take To Vaccinate All Americans? [Video]

How Long Will It Take To Vaccinate All Americans?

There are currently two COVID-19 vaccines promising results from their Phase 3 trials. Moderna announced that its vaccine was 94.5% effective. Pfizer/BioNTech announced that their vaccine was 95% effective. How long will it take for all Americans to be vaccinated? If the FDA approves the vaccine, Business Insider says first responders and vulnerable populations will receive vaccines through March.

Credit: Wochit News    Duration: 00:34Published

Related videos from verified sources

FDA Approves First At-Home Rapid Coronavirus Test [Video]

FDA Approves First At-Home Rapid Coronavirus Test

The 30-minute test kit was developed by California-based company Lucira Health.

Credit: Cover Video STUDIO     Duration: 00:53Published
Daily Covid-19 Minute: Remdesivir Approved By FDA As First Covid-19 Drug [Video]

Daily Covid-19 Minute: Remdesivir Approved By FDA As First Covid-19 Drug

Breaking news in the coronavirus pandemic. The FDA has just approved Gilead’s drug - Remdesivir - as a treatment for Covid-19.

Credit: CBS 62 Detroit     Duration: 01:16Published
Remdesivir becomes first FDA fully-approved coronavirus treatment [Video]

Remdesivir becomes first FDA fully-approved coronavirus treatment

The Food and Drug Administration has approved remdesivir as a treatment for the coronavirus.

Credit: NewsChannel 5 Nashville     Duration: 01:22Published